Pacritinib
PAC203/PAC303
Phase 3 small_molecule active
Quick answer
Pacritinib for Primary Myelofibrosis is a Phase 3 program (small_molecule) at Swedish Orphan Biovitrum AB (publ) with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Swedish Orphan Biovitrum AB (publ)
- Indication
- Primary Myelofibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active